Bayer HealthCare and USAID launch joint Contraceptive Security Initiative
19th January 2011
In December 2010, Bayer HealthCare pharma (BHC) and the Unites States Agency for International Development (USAID) launched the joint "Contraceptive Security Initiative". This initiative aims to grant middle-income earners in sub-Saharan Africa access to oral contraceptives at affordable prices.
Ethiopian women will be the first to benefit from this public-priavte partnership. Women there will be able to purchase Micrgynon® Fe, the most widely used oral contraceptive in the world, at a lower cost. The initiative will benefit from a five-year window during which USAID will underwrite BHC's marketing and promotional costs. “The plan is to create an affordable market for Microgynon® Fe based on local prices—prices which still build in margin enough for Bayer HealthCare to sustain the program, without third-party involvement" explained Klaus Brill, Vice President of Corporate Commercial Relations at BHC. The Ethiopia launch is the first of a phased rollout of the program: ten other sub-Saharan nations will follow, beginning with Uganda and Tanzania in mid-2011.
For more information, visit the BHC website.